Concepedia
Statistics
Publications
10
Citations
706
H-Index
Active since
1983
Affiliations
University of Michigan(Current)
Mayo Clinic
Mayo Clinic in Arizona
WinnMed
Mayo Clinic in Florida
R Lloyd is an author at University of Michigan specializing in medicine, endocrine oncology, and pharmacology.
Publications per year
1983–2007
MC044h, a phase II trial of sorafenib in patients (pts) with metastatic neuroendocrine tumors (NET): A Phase II Consortium (P2C) study
Timothy J. Hobday, Joseph Rubin, Kyle D. Holen et al. · Journal of Clinical Oncology · 2007 · 175 citations
Medicine, Oncology, Pharmacology +16
Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization.
Kálmán Kovács, R Lloyd, Éva Horváth et al. · PubMed · 1989 · 172 citations
Medicine, Endocrinology, Pathology +17
Iodine-131 MIBG scintigraphy of neuroendocrine tumors other than pheochromocytoma and neuroblastoma.
L Von Moll, Alexander McEwan, Brahm Shapiro et al. · PubMed · 1987 · 101 citations
Medicine, Endocrinology, Nuclear Medicine +16
Mutator tRNAs are encoded by the Escherichia coli mutator genes mutA and mutC: a novel pathway for mutagenesis.
Malgorzata M. Slupska, Claudia Baikalov, R Lloyd et al. · Proceedings of the National Academy of Sciences · 1996 · 63 citations · Full text
Life Sciences, Genetics, Microbiology +12
A phase II trial of gefitinib in patients (pts) with progressive metastatic neuroendocrine tumors (NET): A Phase II Consortium (P2C) study
Timothy J. Hobday, Kyle D. Holen, Ross C. Donehower et al. · Journal of Clinical Oncology · 2006 · 62 citations
Medicine, Oncology, Pharmacology +17
1–5 of 10